Wakefit IPO: Price Band Set at Rs 185-195, Subscription to Open on Dec 8
Wakefit Innovations Ltd. has announced the price band for its upcoming initial public offering, with the IPO set to open for subscription on Dec 8 and close on Dec 10.
Blog
Blog
Your blog category
Blog
Varroc Engineering Target Price Upgraded by Investec: Strong Growth and Margin Gains Ahead
Investec has upgraded Varroc Engineering’s target price to Rs 800, citing improving fundamentals and management’s confidence in growth acceleration. What does this mean for Indian investors?
Blog
Bajaj Housing Finance Shares Plummet to Record Low as Promoter Sells Stake Worth Rs 1,580 Crore
Bajaj Housing Finance shares hit a record low after promoter Bajaj Finance announced plans to sell a 2% stake worth Rs 1,580 crore to meet minimum public shareholding requirements.
Blog
Asian Paints Shares Rise After UBS Upgrades Stock to Neutral
Asian Paints shares are trading in the green after UBS upgraded the stock to ‘neutral’ and raised its target price to Rs 3,200, citing a stronger-than-expected Q2 performance and potential for long-term growth.
Blog
Nifty To Hit 29,300 In 2026: Nomura’s Top 20 Stock Picks For Indian Investors
Nomura expects the Nifty to reach 29,300 by 2026, driven by a cyclical recovery in domestic growth and easing valuation concerns. Get the details on their top 20 stock picks for Indian investors.
Blog
Vodafone Idea Share Price Rebounds On Hopes Of AGR Relief: What Indian Investors Need To Know
Vodafone Idea share price rebounds from a two-day slump on hopes of relief for adjusted-gross-revenue dues. Find out what this means for Indian investors and the company’s future prospects.
Blog
Stock Market LIVE Updates: Nifty, Sensex Fall as ICICI Bank, HDFC Bank Shares Weigh
The NSE Nifty 50 and BSE Sensex opened lower on Tuesday as ICICI Bank Ltd. and HDFC Bank Ltd. shares weighed, while Vodafone Idea share price rebounded from a two-day slump.
Blog
Wockhardt Shares Soar Over 11% After USFDA Approval: What Indian Investors Need to Know
Wockhardt Ltd. shares jumped over 11% after receiving USFDA approval for its novel antibiotic, Zaynich. Here’s what this means for Indian investors and the pharma industry.
Blog
Wockhardt Shares Surge: What’s Driving the Rally and What It Means for Indian Investors
Wockhardt Ltd. shares have been on a tear, rising over 5% after the company received USFDA acceptance for its Zaynich antibiotic. What’s driving the rally and how does it impact Indian investors?
Blog
Indian Eyewear Market to Double to $17.2 Billion by 2030: Lenskart
Lenskart Solutions Ltd. forecasts the Indian eyewear market to nearly double to $17.2 billion by 2030, driven by growth in active eyewear users and accessible eye testing infrastructure.